•  
  •  
  •  
  •  

2026-08-13 13:43:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  Authorisation

Stock Report

  • CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
  • Federal Bank gets authorisation to Collect Government Receipts for the State of Maharashtra via GRAS Portal
  • 'Zaakpay' by MobiKwik gets RBI nod to operate as an Online Payment Aggregator
  • AstraZeneca Pharma India Ltd surrenders marketing authorisation for Olaparib 100mg and 150mg
  • BrePco Biopharma and Piramal Critical Care announce MHRA approval for Neoatricon® in the UK
  • European Commission approves Biocon Biologics' Ustekinumab Biosimilar
  • Infibeam Avenues Ltd Receives RBI's Final Authorisation for Payment Aggregator Licence
  • Venus Remedies achieves Marketing Authorizations for Docetaxel in Israel and Cytarabine in Colombia
  • Venus Remedies consolidates global presence with marketing approvals from Philippines, Saudi Arabia for three drugs
  • Biocon Biologics Receives European Commission Approval for YESAFILI®, Biosimilar Aflibercept
  • Venus Remedies gets marketing approval for cancer drugs from Uzbekistan, Palestine
  • CAMS receives in-principle authorisation to operate as a Payment Aggregator
  • Marksans Pharma Ltd announces UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
  • ZIM Laboratories Ltd receives Marketing Authorization for Sildenafil 50 mg Orally Dissolving Film in Spain, Europe
  • ZyCoV-D® as a two-dose vaccine receives EUA from DCGI
  • Marksans Pharma announces UK MHRA approval for Bells Healthcare All in One Oral Solution
  • Control Print receives USFDA 510 (k) authorisation for masks
  • Marksans Pharma Limited announces UK MHRA approval for Loperamide 2mg Hard Capsules

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025